Original article
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study
Comparación entre múltiples dosis de insulina (insulina glargina una vez al día y lispro en las comidas) e infusión subcutánea continua de insulina con monitorización continua de glucosa en pacientes con diabetes tipo 1 metabólicamente optimizados. Estudio randomizado
María Soledad Ruiz-de-Adanaa,b,d, Marta-Elena Dominguez-Lopeza,b,d, Inmaculada Gonzalez-Moleroa,b,d,⽽
, Alberto Machadoc, Victor Martina, Isabel Cardonad, Magdalena de-la-Higuerae, María-José Tapiaa,d, Federico Soriguera,b,d, María Teresa Anartec,d, Gemma Rojo-Martíneza,b,d
Corresponding author
a Diabetes Centre, Department of Endocrinology and Nutrition, General University Hospital of Malaga, Spain
b CIBERDEM (Carlos III Health Institute), Malaga, Spain
c Department of Personality, Assessment and Psychological Treatment, Faculty of Psychology, University of Malaga, Malaga, Spain
d Instituto de Investigación Biomédica de Málaga (IBIMA), Spain
e Department of Endocrinology, Clinical Universitary of Navarra, Pamplona, Navarra, Spain
